Korean Drug Co., Ltd. (KOSDAQ:014570)

Korean Drug Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	43,157	46,922	50,141	78,348	85,441	97,444
Market Cap Growth	-20.66%	-6.42%	-36.00%	-8.30%	-12.32%	-13.30%
Enterprise Value	13,218	17,968	30,087	41,605	53,950	71,749
Last Close Price	3955.00	4300.00	4405.30	6649.24	7098.22	7914.17
PE Ratio	6.63	7.21	16.74	-	7.24	10.78
PS Ratio	0.69	0.75	0.69	0.96	1.07	1.31
PB Ratio	0.52	0.56	0.64	1.02	1.01	1.27
P/TBV Ratio	0.52	0.57	0.64	1.02	1.01	1.27
P/FCF Ratio	3.41	3.71	13.05	-	-	12.72
P/OCF Ratio	3.29	3.58	10.30	-	14.45	11.07
EV/Sales Ratio	0.21	0.29	0.41	0.51	0.68	0.96
EV/EBITDA Ratio	1.49	2.02	4.87	4.91	3.43	5.63
EV/EBIT Ratio	1.91	2.60	7.33	6.19	3.77	6.37
EV/FCF Ratio	1.04	1.42	7.83	-	-	9.37
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.01	0.01	0.01	0.01	0.00
Debt / FCF Ratio	0.01	0.01	0.02	-	-	0.01
Net Debt / Equity Ratio	-0.36	-0.36	-0.24	-0.22	-0.31	-0.36
Net Debt / EBITDA Ratio	-3.37	-3.37	-3.06	-1.97	-1.68	-2.18
Net Debt / FCF Ratio	-2.37	-2.37	-4.92	2.14	146.19	-3.63
Asset Turnover	0.68	0.68	0.82	0.88	0.87	0.87
Inventory Turnover	2.01	2.01	2.01	2.74	3.41	3.67
Quick Ratio	6.41	6.41	5.81	4.52	7.81	5.51
Current Ratio	8.33	8.33	8.73	6.41	9.80	6.82
Return on Equity (ROE)	8.08%	8.08%	3.86%	-6.08%	14.63%	12.26%
Return on Assets (ROA)	4.72%	4.72%	2.87%	4.56%	9.78%	8.19%
Return on Invested Capital (ROIC)	10.97%	10.28%	4.12%	-6.73%	21.49%	18.45%
Return on Capital Employed (ROCE)	8.00%	8.00%	5.00%	8.40%	16.50%	14.40%
Earnings Yield	15.09%	13.88%	5.97%	-6.28%	13.82%	9.28%
FCF Yield	29.32%	26.97%	7.66%	-9.97%	-0.21%	7.86%
Payout Ratio	26.57%	26.57%	54.02%	-	15.52%	18.07%
Buyback Yield / Dilution	-	-	-0.08%	0.01%	1.30%	-0.56%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.